Urinary Catheters Market Report

The rapidly rising prevalence of urine incontinence throughout the world is likely to drive the global market over the forecast period. Furthermore, the Centres for Medicare and Medicaid Services in the United States published "guidelines" for UI treatment in nursing homes and provided staff with web-based training. The "Love Your Gusset" awareness campaign, which intended to raise awareness of the stress UI in women, was also launched in collaboration with the Bladder and Bowel Foundation and Education and Resources for Improving Childhood Continence (ERIC). Furthermore, a change in patient self-care and an increase in educational activities to educate self-catheterization in home care settings are important drivers expected to fuel market expansion during the forecast period.

Additionally, recent advances in urinary catheter technology are greatly improving both patient safety and comfort. One common use of antimicrobial coatings is on catheters to lower infection risk by stopping bacterial growth. Furthermore, self-lubricating materials are being used to reduce friction when inserting and removing, resulting in a more pleasant patient experience. These advancements enhance patient results and provide unique chances for manufacturers to distinguish their products in a competitive market. By integrating these innovative characteristics, businesses can address changing patient demands and differentiate themselves in a quickly progressing healthcare industry.

Urinary catheterization is a difficult procedure that must be performed by skilled medical professionals. Negligence of any type can lead to infections and other issues. The insertion and removal of insufficiently lubricated catheters can generate friction between the urethral walls and the outermost layer of the device, which is not only uncomfortable for the patient but can also lead to urethral narrowing, bleeding and infection with repeated usage. According to the NCBI, CAUTIs, the most frequent kind of nosocomial infection, account for over 1 million cases each year, or more than 40% of all nosocomial infections that occur in hospitals and nursing homes, and account for 80% of all nosocomial UTIs. The availability of alternative treatments and the increasing fear of CAUTIs and the health issues they cause are severely hampering revenue growth. The rising number of product recalls by government agencies such as the United States Food and Drug Administration is projected to stymie industry expansion.

Advancements in urinary catheter systems are urgently needed to improve patient outcomes and comfort. Integrating antimicrobial coatings for infection prevention, using hydrophilic materials for easier insertion, and implementing smart technologies for real-time monitoring can greatly enhance user satisfaction. In addition, concentrating on creating catheters that have better flexibility and less friction can help solve typical problems like discomfort and catheter-related infections. Fulfilling these requirements is crucial for progressing catheter technology and enhancing overall patient care in various healthcare environments. For instance, in May 2024, Coloplast expands its Luja portfolio with next generation catheter for women. The female intermittent catheter enables complete bladder emptying in one free flow aiming to reduce the risk of urinary tract infections. Following the successful launch of Luja with Micro-hole Zone Technology, a next generation intermittent catheter for men, Coloplast is now launching Luja for women. In addition, in May 2024, Laborie Medical Technologies Corp., a leading diagnostic and therapeutic medical technology company, announced positive 2-year and 5-year results from studies for its Optilume® BPH Catheter System.

North America dominated the global market. The increased prevalence of targeted conditions such as bladder obstruction, Benign Prostatic Hyperplasia (BPH), UI, urine retention and bladder cancer are driving the regional market. In accordance to the Urology Care Foundation, between one-quarter to one-third of men and women in the United States suffer with urine incontinence. 33 million Americans suffer with overactive bladder, which includes symptoms including frequency, urgency, and urge incontinence. Urologic disorders are the third most prevalent concern among adults aged 65 and older in the United States, accounting for nearly 47% of all physician visits, according to the American Society of Nephrology. As a result, the rising number of BPH-related surgical operations and increasing cases of bladder cancer are pushing the market in North America.